Aids
(AIDS) 《艾滋病》

2015年影响因子
4.407
- 2012-10-11•丙肝病毒血症可增加HIV患者中慢性肾病发病率
- 2015-05-20•靶向gp41的高度有效的HIV-1融合抑制剂的设计
- 2014-01-11•人免疫系统产生广泛中和性HIV-1抗体的潜力:对疫苗研发的意义
- 2013-08-19•在一个接受抗逆转录病毒治疗的中国患者队列中,HIV耐药对病毒学和免疫学失败和死亡率的影响
- 2013-08-19•CRF01-AE在中国流行的迅速扩大是由20世纪90年代引入的多种HIV-1病毒世系驱动的
- 2012-09-28•一个多中心队列中的人类免疫缺陷病毒/乙型肝炎病毒共感染患者对联合抗逆转录病毒治疗的免疫学与病毒学应答
最新一期

Opinion
The HIV care continuum: no partial credit given
AIDS. 26(14):1735-1738, September 10, 2012.
doi: 10.1097/QAD.0b013e328355d67b

Basic Science
Dual R3R5 tropism characterizes cerebrospinal fluid HIV-1 isolates from individuals with high cerebrospinal fluid viral load
AIDS. 26(14):1739-1744, September 10, 2012.
doi: 10.1097/QAD.0b013e3283560791
Natural killer cell function in women at high risk for HIV acquisition: insights from a microbicide trial
AIDS. 26(14):1745-1753, September 10, 2012.
doi: 10.1097/QAD.0b013e328357724f

Clinical Science
Immunological and virological responses to combined antiretroviral therapy in HIV/hepatitis B virus-coinfected patients from a multicenter cohort
AIDS. 26(14):1755-1763, September 10, 2012.
doi: 10.1097/QAD.0b013e328355ced2
Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load
AIDS. 26(14):1765-1774, September 10, 2012.
doi: 10.1097/QAD.0b013e328355e6b2
Bilateral oblique facial clefts and extremity anomaly in an infant after intrauterine efavirenz exposure and review of its teratogenic risk
AIDS. 26(14):1775-1779, September 10, 2012.
doi: 10.1097/QAD.0b013e328356467a
Comparisons between validated estimated glomerular filtration rate equations and isotopic glomerular filtration rate in HIV patients
AIDS. 26(14):1781-1788, September 10, 2012.
doi: 10.1097/QAD.0b013e328356480d
Insulin resistance is associated with progression to hepatic fibrosis in a cohort of HIV/hepatitis C virus-coinfected patients
AIDS. 26(14):1789-1794, September 10, 2012.
doi: 10.1097/QAD.0b013e32835612ce
Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tablets
AIDS. 26(14):1795-1800, September 10, 2012.
doi: 10.1097/QAD.0b013e32835705fd
Effects of rosuvastatin versus pravastatin on low-density lipoprotein diameter in HIV-1-infected patients receiving ritonavir-boosted protease inhibitor
AIDS. 26(14):1801-1805, September 10, 2012.
doi: 10.1097/QAD.0b013e328357063c
Transient elastography to rule out esophageal varices and portal hypertensive gastropathy in HIV-infected individuals with liver cirrhosis
AIDS. 26(14):1807-1812, September 10, 2012.
doi: 10.1097/QAD.0b013e3283573267

Epidemiology and Social
Phylogenetic insights into regional HIV transmission
AIDS. 26(14):1813-1822, September 10, 2012.
doi: 10.1097/QAD.0b013e3283573244
Treatment outcomes after 7 years of public-sector HIV treatment
AIDS. 26(14):1823-1828, September 10, 2012.
doi: 10.1097/QAD.0b013e328357058a
Differences in the causes of death of HIV-positive patients in a cohort study by data sources and coding algorithms
AIDS. 26(14):1829-1834, September 10, 2012.
doi: 10.1097/QAD.0b013e328352ada4

Editorial Comment
System to classify cause of deaths in HIV-positive persons: time to harmonize
AIDS. 26(14):1835-1836, September 10, 2012.
doi: 10.1097/QAD.0b013e3283577427

Research Letters
Long-term glucose tolerance in highly experienced HIV-infected patients receiving nucleoside analogue-sparing regimens
AIDS. 26(14):1837-1840, September 10, 2012.
doi: 10.1097/QAD.0b013e32835705dd
Increasing sexual risk behaviour among Dutch men who have sex with men: mathematical models versus prospective cohort data
AIDS. 26(14):1840-1843, September 10, 2012.
doi: 10.1097/QAD.0b013e3283574df9

Correspondence
HIV protease inhibitors in combination with boceprevir: are drug–drug interactions the same for all patients?
AIDS. 26(14):1845-1846, September 10, 2012.
doi: 10.1097/QAD.0b013e328357065c
Limitations of proposed novel trial design
AIDS. 26(14):1846-1847, September 10, 2012.
doi: 10.1097/QAD.0b013e32835732ee
Novel clinical trial designs for the development of new antiretroviral agents
AIDS. 26(14):1847-1848, September 10, 2012.
doi: 10.1097/QAD.0b013e3283573326